Christina Yee, MD, PhD
Immunologist, Division of Immunology
Instructor, Harvard Medical School
Image
Christina Yee, MD, PhD
Immunologist, Division of Immunology
Instructor, Harvard Medical School
Medical Services
Languages
English
Education
Medical School
University of Michigan Medical School
2006
Ann Arbor
MI
Residency
Comer Children's Hospital & University of Chicago Medical Center
2009
Chicago
IL
Fellowship
Boston Children's Hospital
2012
Boston
MA
Certifications
American Board of Allergy & Immunology (General)
Publications
Incidence and risk factors for CMV and EBV infection in infants with low T-cell receptor excision circles on newborn screen. View Abstract
T cell and autoantibody profiling for primary immune regulatory disorders. View Abstract
A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings. View Abstract
Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. View Abstract
Acetaminophen Inhibits the Neutrophil Oxidative Burst: Implications for Diagnostic Testing. View Abstract
Expanded genetic insight and clinical experience of DNMT1-complex disorder. View Abstract
An emerging role for endothelial barrier support therapy for congenital disorders of glycosylation. View Abstract
Reply. View Abstract
Acquired Cold-Induced Urticaria in Pediatric Patients: A 22-Year Experience in a Tertiary Care Center (1996-2017). View Abstract
Long-Term Outcome of Peanut Oral Immunotherapy Facilitated Initially by Omalizumab. View Abstract
A twenty-two-year experience with Hymenoptera venom immunotherapy in a US pediatric tertiary care center 1996-2018. View Abstract
Patients with CD3G mutations reveal a role for human CD3? in Treg diversity and suppressive function. View Abstract
Successful rapid oral clindamycin desensitization in a pediatric patient. View Abstract
Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. View Abstract
The Heterogeneity of Oral Immunotherapy Clinical Trials: Implications and Future Directions. View Abstract
Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association. View Abstract
Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. View Abstract
A novel mutation in ORAI1 presenting with combined immunodeficiency and residual T-cell function. View Abstract
Leucine-rich repeat containing 8A (LRRC8A) is essential for T lymphocyte development and function. View Abstract
Successful desensitization to brentuximab vedotin after anaphylaxis. View Abstract
Disruption of MHC class II-restricted antigen presentation by vaccinia virus. View Abstract
Enhanced production of IL-10 by dendritic cells deficient in CIITA. View Abstract
Cathepsin E: a novel target for regulation by class II transactivator. View Abstract
Dendritic cell-specific MHC class II transactivator contains a caspase recruitment domain that confers potent transactivation activity. View Abstract
Effective antigen-specific immunotherapy in the marmoset model of multiple sclerosis. View Abstract
Signaling network of paclitaxel-induced apoptosis in the LNCaP prostate cancer cell line. View Abstract
Carboplatin-induced cell death in model prostate cancer systems. View Abstract
The effect of castanospermine on the metastatic properties of prostate cancer cells. View Abstract
Differential recognition of microfilarial chitinase, a transmission-blocking vaccine candidate antigen, by sera from patients with Brugian and Bancroftian filariasis. View Abstract
Locations